Stay updated on Denosumab with Checkpoint Inhibitors in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Denosumab with Checkpoint Inhibitors in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Denosumab with Checkpoint Inhibitors in Melanoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T14:24:51.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The trial design has been updated to specify a pre-specified number of patients with stage IV M1c disease in each arm, and the collaborators now include Peter MacCallum Cancer Centre, Amgen, and Bristol-Myers Squibb. Additionally, the revision version has changed from v2.14.4 to v2.15.0.
    Difference
    42%
    Check dated 2025-04-16T11:07:30.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T05:12:11.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T22:15:48.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.9%
    Check dated 2025-03-03T22:24:46.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    0.9%
    Check dated 2025-02-10T09:54:16.000Z thumbnail image

Stay in the know with updates to Denosumab with Checkpoint Inhibitors in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Denosumab with Checkpoint Inhibitors in Melanoma Clinical Trial page.